Toxoplasma gondii and schizophrenia
2003

Toxoplasma gondii and Schizophrenia

Sample size: 19 publication Evidence: moderate

Author Information

Author(s): Torrey E. Fuller, Yolken Robert H.

Primary Institution: Stanley Medical Research Institute

Hypothesis

Is there a link between Toxoplasma gondii infection and the development of schizophrenia?

Conclusion

The study suggests that Toxoplasma gondii infection may play a role in the etiology of some cases of schizophrenia.

Supporting Evidence

  • 18 out of 19 studies reported a higher percentage of Toxoplasma antibodies in schizophrenia patients compared to controls.
  • 11 studies showed statistically significant differences in antibody levels.
  • Some medications for schizophrenia inhibit Toxoplasma gondii replication.

Takeaway

Some germs, like Toxoplasma gondii, might make people act differently and could be linked to mental illnesses like schizophrenia.

Methodology

The study reviewed 19 epidemiologic studies on Toxoplasma gondii antibodies in schizophrenia patients and controls.

Potential Biases

Potential bias due to differential exposure to Toxoplasma in hospitalized patients.

Limitations

Some studies may have publication bias, as negative results are less likely to be published.

Participant Demographics

Approximately 1% of the adult population in the United States and Europe is affected by schizophrenia.

Statistical Information

P-Value

<0.0001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3201/eid0911.030143

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication